Transradial Closure Devices Market Report: Trends, Forecast and Competitive Analysis to 2030

Transradial Closure Devices Market Trends and Forecast

The future of the global transradial closure devices market looks promising with opportunities in the hospital, independent catheterization center, ambulatory surgical center, and specialized clinic markets. The global transradial closure devices market is expected to grow with a CAGR of 19.5% from 2024 to 2030. The major drivers for this market are growing preference for minimally invasive procedures worldwide, technological advancements in interventional cardiology, such as the development of smaller and more flexible devices, and rising prevalence of cardiovascular diseases globally, coupled with the aging population.

• Lucintel forecasts that band/strap-based is expected to witness the highest growth over the forecast period.

• Within this market, hospitals is expected to witness the higher growth.

• North America will remain the largest region over the forecast period.

Country Wise Outlook for the Transradial Closure Devices Market

• United States: Company X has launched a next-generation transradial closure device aimed at reducing procedure times and complications. Government initiatives include funding for research into innovative vascular closure technologies to enhance patient outcomes.

• Germany: German companies are investing in the development of bioresorbable transradial closure devices to minimize long-term vascular complications. Targets include achieving regulatory approvals for these advanced devices to improve patient safety and recovery.

• Japan: Japanese firms are focusing on integrating robotic-assisted technologies with transradial closure devices to enhance procedural precision and patient comfort. Government support includes regulatory reforms to expedite approvals for advanced medical devices in cardiovascular interventions.

• India: Company Y has partnered with hospitals to introduce cost-effective transradial closure devices tailored for the Indian market. The government's healthcare initiatives prioritize expanding access to minimally invasive procedures, driving demand for innovative vascular closure solutions. A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Transradial Closure Devices Market by Segment

The study includes a forecast for the global transradial closure devices market by product, usage, application, end use, and region.

Transradial Closure Devices Market by Product [Value from 2018 to 2030]:

• Band/Strap-based

• Knob-based

• Plate-based

Transradial Closure Devices Market by Usage [Value from 2018 to 2030]:

• Disposable

• Reusable

Transradial Closure Devices Market by Application [Value from 2018 to 2030]:

• Surgical Intervention

• Diagnostics

Transradial Closure Devices Market by End Use [Value from 2018 to 2030]:

• Hospitals

• Independent Catheterization Centers

• Ambulatory Surgical Centers

• Specialized Clinics

Transradial Closure Devices Market by Region [Value from 2018 to 2030]:

• North America

• Europe

• Asia Pacific

• The Rest of the World

List of Transradial Closure Devices Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies transradial closure devices companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transradial closure devices companies profiled in this report include-

• Merit Medical

• Abbott Laboratories

• Vascular Solution

• Advanced Vascular Dynamics

• Comed B.V.

• Fisher & Paykel Healthcare Corporation

• Beijing Demax Medical Technology

Recent Development in the Transradial Closure Devices Market

• Terumo Corporation: Terumo Corporation has launched a novel transradial closure device featuring advanced hemostatic technology. The device offers precise vascular closure with reduced procedural times and enhanced patient comfort, catering to the growing demand for minimally invasive cardiac interventions.

• Abbott Laboratories: Abbott Laboratories has introduced a portfolio expansion of its transradial closure devices, emphasizing enhanced safety and efficacy in radial artery closure. The new devices incorporate ergonomic designs and improved hemostatic mechanisms, supporting efficient hemostasis and minimizing post-procedural complications.

• Merit Medical Systems, Inc.: Merit Medical Systems has announced the acquisition of a company specializing in innovative vascular closure technologies. This strategic move aims to broaden Merit's transradial closure device offerings, focusing on advancing procedural outcomes and expanding market presence globally.

• Cardinal Health, Inc.: Cardinal Health has partnered with leading hospitals to conduct clinical trials on a next-generation transradial closure device. The device integrates real-time monitoring capabilities and ergonomic features to optimize procedural efficiency and patient safety, setting new standards in vascular closure technology.

• Teleflex Incorporated: Teleflex Incorporated has launched a patient-centric initiative to enhance patient education and training on the use of transradial closure devices. The initiative includes educational resources and support tools aimed at improving patient outcomes and reducing complications associated with radial artery access procedures.

Features of the Global Transradial Closure Devices Market

Market Size Estimates: Transradial closure devices market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions. Segmentation Analysis: Transradial closure devices market size by various segments, such as product, usage, application, end use, and region in terms of value ($B). Regional Analysis: Transradial closure devices market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different products, usages, applications, end uses, and regions for the transradial closure devices market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the transradial closure devices market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the growth forecast for transradial closure devices market? Answer: The global transradial closure devices market is expected to grow with a CAGR of 19.5% from 2024 to 2030. Q2. What are the major drivers influencing the growth of the transradial closure devices market? Answer: The major drivers for this market are growing preference for minimally invasive procedures worldwide, technological advancements in interventional cardiology, such as the development of smaller and more flexible devices, and rising prevalence of cardiovascular diseases globally, coupled with the aging population. Q3. What are the major segments for transradial closure devices market? Answer: The future of the transradial closure devices market looks promising with opportunities in the hospital, independent catheterization center, ambulatory surgical center, and specialized clinic markets. Q4. Who are the key transradial closure devices market companies? Answer: Some of the key transradial closure devices companies are as follows:

• Merit Medical

• Abbott Laboratories

• Vascular Solution

• Advanced Vascular Dynamics

• Comed B.V.

• Fisher & Paykel Healthcare Corporation

• Beijing Demax Medical Technology Q5. Which transradial closure devices market segment will be the largest in future? Answer: Lucintel forecasts that band/strap-based is expected to witness the highest growth over the forecast period. Q6. In transradial closure devices market, which region is expected to be the largest in next 5 years? Answer: North America will remain the largest region over the forecast period. Q7. Do we receive customization in this report? Answer: Yes, Lucintel provides 10% customization without any additional cost.